NEW YORK (

TheStreet

) --

MannKind Corporation

(Nasdaq:

MNKD

) hit a new 52-week low Wednesday as it is currently trading at $3.39, below its previous 52-week low of $3.40 with 67,420 shares traded as of 10:02 a.m. ET. Average volume has been 955,800 shares over the past 30 days.

MannKind has a market cap of $457.4 million and is part of the

health care

sector and

drugs

industry. Shares are down 57.3% year to date as of the close of trading on Tuesday.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer.

  • Practice your MNKD trading strategies and win cash in our stock game.

TheStreet Ratings rates MannKind as a

sell

. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full

MannKind Ratings Report

.

See all

52-week low stocks

or get investment ideas from our

investment research center

.

null